logo

For the Inventor, By the Inventor

Newton, MA, United States of America

Melissa Marie Vasbinder

This inventor holds 12 USPTO granted patents and 13 published patent applications and 2 EPO patents. Top assignee: Ribon Therapeutics, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melissa Marie Vasbinder. Retrieved from https://idiyas.com/inventor/melissa-marie-vasbinder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 34(Granted Patents)


Location History:

  • Cambridge, MA (US) (2022)
  • Newton, MA (US) (2020 - 2024)

Company Filing History:

goldMedal12 out of 12 
 
Ribon Therapeutics, Inc.
 patents

Years Active: 2020-2026

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 12617782 - Pyridazinones as PARP7 inhibitors (2026-05-05),
2. 12371421 - Solid forms of a PARP7 inhibitor (2025-07-29),
3. 11958837 - Quinazolinones as PARP14 inhibitors (2024-04-16),
4. 11691969 - Pyridazinones as PARP7 inhibtors (2023-07-04),
5. 11566020 - Pyridazinones as PARP7 inhibitors (2023-01-31),
6. 11535621 - Heterobicyclic amides as inhibitors of CD38 (2022-12-27),
7. 11293927 - Screening methods for PARP modulators (2022-04-05),
8. 11014913 - Pyridazinones as PARP7 inhibitors (2021-05-25),
9. 11008308 - Quinazolinones as PARP14 inhibitors (2021-05-18),
10. 10870641 - Pyridazinones as PARP7 inhibitors (2020-12-22),
11. 10562891 - Quinazolinones as PARP14 inhibitors (2020-02-18),
12. 10550105 - Pyridazinones as PARP7 inhibitors (2020-02-04),

Title: Melissa Marie Vasbinder: Innovator in Cancer Treatment

Introduction

Melissa Marie Vasbinder is a prominent inventor based in Newton, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. With a total of 12 patents to her name, she continues to push the boundaries of medical science.

Latest Patents

Among her latest patents is the invention titled "Solid forms of a PARP7 inhibitor." This invention relates to solid forms of the poly(ADP-ribose) polymerase 7 (PARP7) inhibitor, which is useful in the treatment of cancer. Another notable patent is "Quinazolinones as PARP14 inhibitors," which focuses on quinazolinones and related compounds that serve as inhibitors of PARP14, also aimed at treating cancer and inflammatory diseases.

Career Highlights

Melissa is currently associated with Ribon Therapeutics, Inc., where she applies her expertise in drug development. Her work has been instrumental in advancing therapeutic options for patients suffering from cancer.

Collaborations

Throughout her career, Melissa has collaborated with notable colleagues, including Kevin Wayne Kuntz and Laurie B Schenkel. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Melissa Marie Vasbinder stands out as a dedicated inventor whose work is making a significant impact in the field of cancer treatment. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…